These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 33244856)
41. In search for a panacea for coronavirus disease-19: Analysis of ongoing clinical trials for the management of coronavirus disease-19 pandemic in India. Maheshwari N; Roy V Indian J Pharmacol; 2022; 54(4):258-269. PubMed ID: 36204809 [TBL] [Abstract][Full Text] [Related]
42. A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19). Gupta P Indian J Tuberc; 2021 Jan; 68(1):92-98. PubMed ID: 33641858 [TBL] [Abstract][Full Text] [Related]
43. Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations. Fatima U; Rizvi SSA; Raina N; Fatima S; Rahman S; Kamal MA; Hassan MI Curr Pharm Des; 2021; 27(41):4223-4231. PubMed ID: 33238869 [TBL] [Abstract][Full Text] [Related]
44. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series. Thibodeaux K; Speyrer M; Raza A; Yaakov R; Serena TE J Wound Care; 2020 May; 29(Sup5a):S4-S8. PubMed ID: 32412891 [TBL] [Abstract][Full Text] [Related]
46. Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019. Zeng QL; Yu ZJ; Gou JJ; Li GM; Ma SH; Zhang GF; Xu JH; Lin WB; Cui GL; Zhang MM; Li C; Wang ZS; Zhang ZH; Liu ZS J Infect Dis; 2020 Jun; 222(1):38-43. PubMed ID: 32348485 [TBL] [Abstract][Full Text] [Related]
47. Clinical update on COVID-19 for the emergency and critical care clinician: Medical management. Long B; Chavez S; Carius BM; Brady WJ; Liang SY; Koyfman A; Gottlieb M Am J Emerg Med; 2022 Jun; 56():158-170. PubMed ID: 35397357 [TBL] [Abstract][Full Text] [Related]
48. Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea. Ahn JY; Sohn Y; Lee SH; Cho Y; Hyun JH; Baek YJ; Jeong SJ; Kim JH; Ku NS; Yeom JS; Roh J; Ahn MY; Chin BS; Kim YS; Lee H; Yong D; Kim HO; Kim S; Choi JY J Korean Med Sci; 2020 Apr; 35(14):e149. PubMed ID: 32281317 [TBL] [Abstract][Full Text] [Related]
50. No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. Nomoto H; Kutsuna S; Okuma K; Kuramitsu M; Tezuka K; Ikebe E; Saito S; Kinoshita N; Terada M; Endo M; Suzuki T; Miyazato Y; Nakamoto T; Inada M; Hamaguchi I; Ohmagari N J Infect Chemother; 2021 Apr; 27(4):653-655. PubMed ID: 33487533 [TBL] [Abstract][Full Text] [Related]
51. Antiviral therapy for coronavirus disease 2019. Gong S; Su J; Yan X; Li F; Hu L; Liu S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):598-602. PubMed ID: 32879113 [TBL] [Abstract][Full Text] [Related]
52. COVID-19 in Children: Clinical Approach and Management. Sankar J; Dhochak N; Kabra SK; Lodha R Indian J Pediatr; 2020 Jun; 87(6):433-442. PubMed ID: 32338347 [TBL] [Abstract][Full Text] [Related]
53. Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS). Ma X; Liang M; Ding M; Liu W; Ma H; Zhou X; Ren H Med Sci Monit; 2020 Aug; 26():e925364. PubMed ID: 32759887 [TBL] [Abstract][Full Text] [Related]
54. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Martinot M; Jary A; Fafi-Kremer S; Leducq V; Delagreverie H; Garnier M; Pacanowski J; Mékinian A; Pirenne F; Tiberghien P; Calvez V; Humbrecht C; Marcelin AG; Lacombe K Clin Infect Dis; 2021 Oct; 73(7):e1762-e1765. PubMed ID: 32986807 [TBL] [Abstract][Full Text] [Related]
55. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. Wiersinga WJ; Rhodes A; Cheng AC; Peacock SJ; Prescott HC JAMA; 2020 Aug; 324(8):782-793. PubMed ID: 32648899 [TBL] [Abstract][Full Text] [Related]
57. Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review. Mehraeen E; Najafi Z; Hayati B; Javaherian M; Rahimi S; Dadras O; SeyedAlinaghi S; Ghadimi M; Sabatier JM Infect Disord Drug Targets; 2022; 22(1):e260721194968. PubMed ID: 34313204 [TBL] [Abstract][Full Text] [Related]
58. Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia. Abe T; Izumo T; Ueda A; Hayashi M; Ishibashi Y CEN Case Rep; 2021 Feb; 10(1):42-45. PubMed ID: 32715376 [TBL] [Abstract][Full Text] [Related]
59. Controversial treatments: An updated understanding of the coronavirus disease 2019. Zhang C; Huang S; Zheng F; Dai Y J Med Virol; 2020 Sep; 92(9):1441-1448. PubMed ID: 32219882 [TBL] [Abstract][Full Text] [Related]
60. COVID-19: a wreak havoc across the globe. Rehman H; Ahmad MI Arch Physiol Biochem; 2023 Feb; 129(1):82-94. PubMed ID: 32730095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]